Resveratrol: A candidate nutritional substance for prostate cancer prevention

Journal of Nutrition

Volumn 133, Issue 7 SUPPL., 2003, Pages

  Stewart, Jubilee R ^a   Artime, Marlene C ^a   O'Brian, Catherine A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Dietary polyphenols; Epidermal growth factor receptor (EGFR); Prostate cancer prevention; Protein kinase C (PKC); Resveratrol

Indexed keywords

ANDROGEN RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; POLYPHENOL; RESVERATROL; STILBENE;

AUTOCRINE EFFECT; CANCER PREVENTION; CHEMICAL CARCINOGENESIS; CONFERENCE PAPER; DRUG MECHANISM; DRUG STRUCTURE; GRAPE; HORMONE DEPENDENCE; NUTRITION; PEANUT; PROSTATE CANCER; RECEPTOR BLOCKING;

ANIMALIA; ARACHIS HYPOGAEA; VITACEAE; VITIS SP.;

EID: 0038337987     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/133.7.2440s     Document Type: Conference Paper

References (36)

1. Milner, J. A., McDonald, S. S., Anderson, D. E. & Greenwald, P. (2001) Molecular targets for nutrients involved with cancer prevention. Nutr. Cancer 41: 1-16.
2. Gusman, J., Malonne, H. & Atassi, G. (2001) A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis 22: 1111-1117.
3. Bertelli, A. A., Giovannini, L., Stradi, R., Bertelli, A. & Tillement, J. P. (1996) Plasma, urine and tissue levels of trans- and cis-resveratrol (3,4′,5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats. J. Int. J. Tissue React. 18: 67-71.
4. Soleas, G. J., Diamandis, E. P. & Goldberg, D. M. (2001) The world of resveratrol. Adv. Exp. Med. Biol. 492: 159-182.
5. Juan, M. E., Vinardell, M. P. & Planas, J. M. (2002) The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful. J. Nutr. 132: 257-260.
6. Hursting, S. D., Slaga, T. J., Fischer, S. M., DiGiovanni, J. & Phang, J. M. (1999) Mechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice. J. Natl. Cancer Inst. 91: 215-225.
7. Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W., Fong, H. H., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., Moon, R. C. & Pezzuto, J. M. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220.
8. Stewart, J. R., Ward, N. E., Ioannides, C. G. & O'Brian, C. A. (1999) Resveratrol preferentially inhibits protein kinase C-catalyzed phosphorylation of a cofactor-independent, arginine-rich protein substrate by a novel mechanism. Biochemistry 38: 13244-13251.
9. Stewart, J. R., Christman, K. L. & O'Brian, C. A. (2000) Effects of resveratrol on the autophosphorylation of phorbol ester-responsive protein kinases: inhibition of protein kinase D but not protein kinase C isozyme autophosphorylation. Biochem. Pharmacol. 60: 355-359.
10. Gehm, B. D., McAndrews, J. M., Chien, P. Y. & Jameson, J. L. (1997) Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc. Natl. Acad. Sci. U.S.A. 94: 138-143.
11. Bhat, K. P., Lantvit, D. & Christov, K. (2001) Mehta, R. G., Moon, R. C. & Pezzuto, J. M. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Res. 61: 7456-7463.
12. Mitchell, S. H., Zhu, W. & Young, C. Y. (1999) Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells. Cancer Res. 59: 5892-5895.
13. Fontecave, M., Lepoivre, M., Elleingand, E., Gerez, C. & Guittet, O. (1998) Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett. 421: 277-279.
14. Stojanovic, S., Sprinz, H. & Brede, O. (2001) Efficiency and mechanism of the antioxidant action of trans-resveratrol and its analogues in the radical liposome oxidation. Arch. Biochem. Biophys. 391: 79-89.
15. Ciolino, H. P. & Yeh, G. C. (1999) Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Mol. Pharmacol. 56: 760-767.
16. Ron, D. & Kazanietz, M. G. (1999) New insights into the regulation of protein kinase C and novel phorbol ester receptors. FASEB J. 13: 1658-1676.
17. Mellor, H. & Parker, P. J. (1998) The extended protein kinase C superfamily. Biochem. J. 332: 281-292.
18. Subbaramaiah, K., Chung, W. J., Michaluart, P., Telang, N., Tanabe, T., Inoue, H., Jang, M., Pezzuto, J. M. & Dannenberg, A. J. (1998) Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem. 273: 21875-21882.
19. Kimura, Y. & Okuda, H. (2001) Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice. J. Nutr. 131: 1844-1849.
20. Brakenhielm, E., Cao, R. & Cao, Y. (2001) Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes. FASEB J. 15: 1798-1800.
21. Ahmad, N., Adhami, V. M., Afaq, F., Feyes, D. K. & Mukhtar, H. (2001) Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin. Cancer Res. 7: 1466-1473.
22. Mouria, M., Gukovskaya, A. S., Jung, Y., Buechler, P., Hines, O. J., Reber, H. A. & Pandol, S. J. (2002) Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis. Int. J. Cancer 98: 761-769.
23. Huang, C., Ma, W. Y., Goranson, A. & Dong, Z. (1999) Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis 20: 237-242.
24. Tinhofer, I., Bernhard, D., Senfter, M., Anether, G., Loeffler, M., Kroemer, G., Kofler, R., Csordas, A. & Greil, R. (2001) Resveratrol, a tumor-suppressive compound from grapes, induces apoptosis via a novel mitochondrial pathway controlled by Bcl-2. FASEB J. 15: 1613-1615.
25. Holmes-McNary, M. & Baldwin, A. S., Jr. (2000) Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase. Cancer Res. 60: 3477-3483.
26. Hsieh, T. C. & Wu, J. M. (2000) Grape-derived chemopreventive agent resveratrol decreases prostate-specific antigen (PSA) expression in LNCaP cells by an androgen receptor (AR)-independent mechanism. Anticancer Res. 20: 225-228.
27. Denmeade, S. R., Lin, X. S. & Isaacs, J. T. (1996) Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer. Prostate 28: 251-265.
28. Denmeade, S. R. & Isaacs, J. T. (1997) Prostate cancer: where are we and where are we going? Br. J. Urol. 79: 2-7.
29. Gioeli, D., Mandell, J. W., Petroni, G. R., Frierson, H. F., Jr. & Weber, M. J. (1999) Activation of mitogen-activated protein kinase associated with prostate cancer progression. Cancer Res. 59: 279-284.
30. Price, D. T., Rocca, G. D., Guo, C., Ballo, M. S., Schwinn, D. A. & Luttrell, L. M. (1999) Activation of extracellular signal-regulated kinase in human prostate cancer. J. Urol. 162: 1537-1542.
31. Yeh, S., Lin, H. K., Kang, H.-Y., Thin, T. H., Lin, M. F. & Chang, C. (1999) From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells. Proc. Natl. Acad. Sci. U.S.A. 96: 5458-5463.
32. Prenzel, N., Zwick, E., Daub, H., Leserer, M., Abraham, R., Wallasch, C. & Ullrich, A. (1999) EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402: 884-888.
33. Putz, T., Culig, Z., Eder, I. E., Nessler-Menardi, C., Bartsch, G., Grunicke, H., Uberall, F. & Klocker, H. (1999) Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen activated protein kinase pathway in prostate cancer cell lines. Cancer Res. 59: 227-233.
34. Chen, N., Ma, W.-Y., She, Q. B., Wu, E., Liu, G., Bode, A. M. & Dong, Z. (2001) Transactivation of the epidermal growth factor receptor is involved in 12-O-tetradecanoylphorbol-13-acetate-induced signal transduction. J. Biol. Chem. 276: 46722-46728.
35. Scher, H. I., Sarkis, A., Reuter, V., Cohen, D., Netto, G., Petrylak, D., Lianes, P., Fuks, Z., Mendelsohn, J. & Cordon-Cardo, C. (1995) Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms. Clin. Cancer Res. 1: 545-550.
36. Prewett, M., Rockwell, P., Rockwell, R. F., Giorgio, N. A., Mendelsohn, J., Scher, H. I. & Goldstein, N. I. (1996) The biologic effects of C225, a chimeric monoclonal antibody to the EGFR, on human prostate carcinoma. J. Immunother. 19: 419-427.